XML 85 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
May 31, 2012
Cash flows from operating activities:    
Net loss $ (40,048) $ (16,989)
Adjustments to reconcile net loss to net cash used in operating activities:    
Employee stock-based compensation expense 3,594 2,303
Consultant stock-based compensation expense 3 46
Fair value adjustment of common stock warrants 5,981 877
Amortization of intangible assets 86 73
Depreciation of fixed assets 78 27
Realized gain on sale of fixed assets (12) 0
Realized loss on short-term investments 129 0
Unrealized gain on short-term investments 0 (176)
Amortization of debt issuance costs 151 0
Amortization of deferred offering costs 196 0
Changes in assets and liabilities:    
Accounts receivable, net (26) 0
ATM receivable, net (5,250) 0
Inventories (225) 0
Prepaid expenses and other (1,196) (2,116)
Intangible assets (750) 0
Deposits (115) 0
Accounts payable (2,284) (353)
Accrued liabilities 3,944 1,348
Deferred rent (6) (1)
Net cash used in operating activities (35,750) (14,961)
Cash flows from investing activities:    
Purchase of fixed assets (616) (272)
Sale of fixed assets 27 0
Change in restricted cash (50) (56)
Purchase of short-term investments (147) (188)
Sale of short-term investments 22,114 5,000
Net cash provided by investing activities 21,328 4,484
Cash flows from financing activities:    
Proceeds from the sale of common stock under an ATM sales agreement 23,261 352
Proceeds from the exercise of common stock warrants 6,706 3,057
Proceeds from the exercise of common stock options 7 227
Note payable 25,000 0
Fundraising costs (894) (12)
Debt issuance costs (1,257) 0
Deferred offering costs (107) (120)
Capital lease, net 50 11
Net cash provided by financing activities 52,766 3,515
Effect of exchange rates on cash and cash equivalents (89) (9)
Net increase (decrease) in cash and cash equivalents 38,255 (6,971)
Cash and cash equivalents, beginning of period 36,313 [1] 24,732
Cash and cash equivalents, end of period 74,568 17,761
Supplemental cash flow information:    
Interest paid 1,647 0
Supplemental disclosure of non-cash financing activities:    
Fair value of warrant liability reclassified to equity upon exercise 8,918 7,107
Acquisition of equipment in exchange for capital lease $ 68 $ 13
[1] Derived from the Company's audited consolidated financial statements as of December 31, 2012.